Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial (Q82779804)
scientific article published on 01 March 2006
Language:
(P31) (Q13442814)
(P50) (Q57006172)
(Q88613774)
(Q37066728)
(P304) 325-334
(P433) 3
(P478) 4
(P577) Wednesday, March 1, 2006
(P921) (Q269829)
(Q1472)
(Q108853737)
(P1433) (Q5133759)
(P1476) "Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial" (language: en)
(P2093) Stefan Schreiber
Brian Feagan
Jean-Frederic Colombel
Karel Geboes
Mikhail Yurcov
Oleg Golovenko
Diether Ludwig
Trevor Winter
Ulrich Meier
Chan Yong
Jürgen Steffgen
BIRB 796 Study Group
other details
description scientific article published on 01 March 2006

External Links